Medical Condition News

RSS

Study confirms benefits of low-dose spiral CT scans for lung cancer detection

The New England Journal of Medicine's (NEJM) headline today read, "Reduced Lung Cancer Mortality with Low-Dose Computed Tomographic CT Screening," ending a long controversy over the use of an existing but underutilized early detection tool for those at risk for Lung Cancer. Preliminary results of the National Lung Screening Trial (NLST) were first released on November 4, 2010 and confirmed today.

30 Jun 2011

Auxilium reports three year data from XIAFLEX CORDLESS study in Dupuytren's contracture

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced three year recurrence data from the Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study (CORDLESS) for XIAFLEX® (collagenase clostridium histolyticum) in the treatment of adult Dupuytren's contracture patients with a palpable cord.

30 Jun 2011

Chiropractors report high number of back-related injuries during summer moving period

Each year, chiropractors notice a recrudescence of patients that come for a consultation during the summer moving period. Not surprising when we know that many people, eager and tired, hasten to get everything done rapidly without worrying about their muscles and their back. That explains why herniated discs, lumbar pain and muscle soreness are so common during this time of year. How can we avoid this?

30 Jun 2011

PENNSAID Viscous Solution Phase 2 clinical trial for osteoarthritis pain meets primary endpoint

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced receipt from Mallinckrodt Inc., a Covidien company (Covidien), of top-line results from a Phase 2 study conducted by Covidien, of twice-daily administration of PENNSAID Viscous Solution (topical diclofenac sodium viscous solution) 2% w/w, previously referred to as PENNSAID Gel.

30 Jun 2011

Lotus Tissue Repair to develop DEB protein replacement therapy with $26 million Series A financing

Lotus Tissue Repair, Inc. today announced the closing of a $26 million Series A financing led by Third Rock Ventures. Proceeds of the financing will be used to advance the company's proprietary recombinant collagen type VII (rC7) technology as the first and only protein replacement therapy in development for the treatment of dystrophic epidermolysis bullosa (DEB), an orphan disease that causes devastating skin blisters, morbidity and early mortality.

30 Jun 2011

Harvard University, UCB enter innovative research collaboration

UCB and Harvard University officially launched their innovative Research Alliance during a signing ceremony that took place in Boston last night in the presence of his Royal Highness Prince Philippe of Belgium.

30 Jun 2011

Workers who take mental health leave more likely to have second episode sooner

The recurrence of an employee's medical leave of absence from work tends to happen much sooner with a mental health leave than a physical one, a Centre for Addiction and Mental Health (CAMH) study shows.

30 Jun 2011

IOM report can set the stage for improvements in pain care, says APS

The American Pain Society (APS) said that "Relieving Pain in America: A Blueprint for Transforming Prevention, Treatment, and Research, the report submitted to Congress today by the Institute of Medicine, is a major step forward in addressing the nation's leading public health problem - untreated and undertreated chronic pain.

30 Jun 2011

Study about U.S. attitudes toward human embryonic stem cell research

While research using human embryonic stem cells has roused political controversy for almost two decades, little has been done to scientifically assess American attitudes on the subject. New research from the University of Nevada, Reno provides decision-makers with a much clearer picture of how their constituents truly feel about the subject.

30 Jun 2011

New medical contrast agent could play important role in diagnosing colon cancer

Colon cancer could become easier to detect, thanks to a newly developed medical contrast agent and advanced optics that illuminate dangerous, invisible polyps.

30 Jun 2011

Researchers discover Foxj1 genetic 'conductor' responsible for new brain cell production

A team of North Carolina State University researchers has discovered more about how a gene connected to the production of new brain cells in adults does its job. Their findings could pave the way to new therapies for brain injury or disease.

30 Jun 2011

Coffee protects against Alzheimer's disease

The study appears online in the Journal of Alzheimer’s Disease, was in mice whose DNA had been tweaked to contain a human Alzheimer’s gene. Just like humans with familial Alzheimer’s, these mice become increasingly forgetful as they age. It was seen that the equivalent of four to five cups of caffeinated coffee every few days led to much improved memories in the Alzheimer’s mice, says study co-author Gary Arendash, a scientist at the Florida Alzheimer’s Disease Research Center in Tampa.

30 Jun 2011

New classification for assessing functional status and disability in patients with osteoporosis

A new study brings the experience of physical therapists to a developing "Core Set" of criteria to guide evaluation and treatment for patients with osteoporosis, reports the April/June issue of the Journal of Geriatric Physical Therapy, official journal of the Section on Geriatrics of the American Physical Therapy Association.

30 Jun 2011

Energy density, portion size and eating occasions contribute to obesity epidemic in the U.S.

Over the past 30 years U.S. adults have been eating larger portions and eating more often, according to a new study by University of North Carolina at Chapel Hill researchers.

30 Jun 2011

EHRA, Cardiostim partner to develop common scientific programme committee

EHRA-Europace and Cardiostim, Europe's leading congresses in "electrophysiology" and the treatment of heart rhythm disorders have formed a strategic alliance to ensure the development from year to year of a homogeneous congress programme devised under the direction of a common scientific committee.

30 Jun 2011

100 million Americans suffer pain - many in silence

According to a report released by the Institute of Medicine Wednesday, nearly a third of Americans experience long-lasting pain and too often feel stigma rather than relief from a health care system poorly prepared to treat them. Chronic pain is costing the nation at least $558 billion a year in medical bills, sick days and lost productivity, the report found. That's more than the cost of heart disease, the top killer.

30 Jun 2011

MEDICREA launches GRANVIA-C pre-IDE pilot trial for treatment of spinal pathologies

The MEDICREA Group, listed on Alternext by NYSE Euronext Paris, a medical device company specialized in the development of innovative surgical technologies for the treatment of spinal pathologies, reaffirmed its ambitious marketing schedule today for GRANVIA-C, its next-generation cervical disc prosthesis, and also announced the launch of a pre-IDE pilot trial with a view to initiating the approval process in the United States.

30 Jun 2011

Study provides novel information about clinical potential of anti-cancer antibiotics

Most of us have had a doctor prescribe an antibiotic for a stubborn bacterial infection, or for a cut that gets infected. However, prescribing an antibiotic to fight cancer? In fact, anti-cancer antibiotics have been used since the 1950s to successfully treat several forms of cancer, but often the side effects limit the duration they can be given to a patient.

30 Jun 2011

ESC Congress 2011 to spotlight 'controversial issues in cardiology'

The scientific programme for this year's ESC Congress, which will take place in Paris from 27-31 August, is now complete and promises to provide journalists with a rich source of front-page news stories and background for topical features.

30 Jun 2011

NLST: CT screening reduces lung cancer specific mortality by 20%

Current and former heavy smokers can now be screened more effectively for lung cancer. Results from the National Lung Screening Trial (NLST) revealed that detecting small lung cancers with computed tomography (CT) reduces lung cancer specific mortality by 20 percent.

30 Jun 2011

Medical Condition News

Study confirms benefits of low-dose spiral CT scans for lung cancer detection

Auxilium reports three year data from XIAFLEX CORDLESS study in Dupuytren's contracture

Chiropractors report high number of back-related injuries during summer moving period

PENNSAID Viscous Solution Phase 2 clinical trial for osteoarthritis pain meets primary endpoint

Lotus Tissue Repair to develop DEB protein replacement therapy with $26 million Series A financing

Harvard University, UCB enter innovative research collaboration

Workers who take mental health leave more likely to have second episode sooner

IOM report can set the stage for improvements in pain care, says APS

Study about U.S. attitudes toward human embryonic stem cell research

New medical contrast agent could play important role in diagnosing colon cancer

Researchers discover Foxj1 genetic 'conductor' responsible for new brain cell production

Coffee protects against Alzheimer's disease

New classification for assessing functional status and disability in patients with osteoporosis

Energy density, portion size and eating occasions contribute to obesity epidemic in the U.S.

EHRA, Cardiostim partner to develop common scientific programme committee

100 million Americans suffer pain - many in silence

MEDICREA launches GRANVIA-C pre-IDE pilot trial for treatment of spinal pathologies

Study provides novel information about clinical potential of anti-cancer antibiotics

ESC Congress 2011 to spotlight 'controversial issues in cardiology'

NLST: CT screening reduces lung cancer specific mortality by 20%

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News